Tenet Healthcare (THC) Advances While Market Declines: Some Information for Investors
Tenet Healthcare (THC) closed the most recent trading day at $205.12, moving +1.37% from the previous trading session. The stock outperformed the S&P 500, which registered a daily loss of 0.53%. Meanwhile, the Dow lost 0.71%, and the Nasdaq, a tech-heavy index, lost 0.93%. Prior to today's trading, shares of the hospital operator had gained 4.8% outpaced the Medical sector's gain of 3.64% and the S&P 500's gain of 1.13%.Investors will be eagerly watching for the performance of Tenet Healthcare in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on October 28, 2025. It is anticipated that the company will report an EPS of $3.33, marking a 13.65% rise compared to the same quarter of the previous year. In the meantime, our current consensus estimate forecasts the revenue to be $5.24 billion, indicating a 2.22% growth compared to the corresponding quarter of the prior year. Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $15.82 per share and revenue of $21.16 billion, indicating changes of +33.16% and +2.38%, respectively, compared to the previous year. Investors should also take note of any recent adjustments to analyst estimates for Tenet Healthcare. Such recent modifications usually signify the changing landscape of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook. Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system. The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 0.17% lower within the past month. Tenet Healthcare currently has a Zacks Rank of #4 (Sell). Digging into valuation, Tenet Healthcare currently has a Forward P/E ratio of 12.79. This valuation marks a premium compared to its industry average Forward P/E of 10.12. Also, we should mention that THC has a PEG ratio of 0.87. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. THC's industry had an average PEG ratio of 0.87 as of yesterday's close. The Medical - Hospital industry is part of the Medical sector. With its current Zacks Industry Rank of 210, this industry ranks in the bottom 15% of all industries, numbering over 250. The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions. Beyond Nvidia: AI's Second Wave Is HereThe AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. Little-known AI firms tackling the world's biggest problems may be more lucrative in the coming months and years.See "2nd Wave" AI stocks now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Tenet Healthcare Corporation (THC): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Quelle: Zacks
Nachrichten zu Tenet Healthcare Corp.
Keine Nachrichten im Zeitraum eines Jahres in dieser Kategorie verfügbar.
Eventuell finden Sie Nachrichten, die älter als ein Jahr sind, im Archiv
Analysen zu Tenet Healthcare Corp.
Datum | Rating | Analyst | |
---|---|---|---|
26.11.2012 | Tenet Healthcare neutral | Robert W. Baird & Co. Incorporated | |
25.09.2012 | Tenet Healthcare neutral | UBS AG | |
17.05.2012 | Tenet Healthcare overweight | Barclays Capital | |
10.05.2012 | Tenet Healthcare overweight | Barclays Capital | |
02.04.2012 | Tenet Healthcare overweight | Barclays Capital |
Datum | Rating | Analyst | |
---|---|---|---|
17.05.2012 | Tenet Healthcare overweight | Barclays Capital | |
10.05.2012 | Tenet Healthcare overweight | Barclays Capital | |
02.04.2012 | Tenet Healthcare overweight | Barclays Capital | |
03.11.2011 | Tenet Healthcare overweight | Barclays Capital | |
04.08.2011 | Tenet Healthcare overweight | Barclays Capital |
Datum | Rating | Analyst | |
---|---|---|---|
26.11.2012 | Tenet Healthcare neutral | Robert W. Baird & Co. Incorporated | |
25.09.2012 | Tenet Healthcare neutral | UBS AG | |
03.11.2011 | Tenet Healthcare sector perform | RBC Capital Markets | |
21.07.2010 | Tenet Healthcare neutral | UBS AG | |
02.06.2010 | Tenet Healthcare Downgrade | Robert W. Baird & Co. Incorporated |
Datum | Rating | Analyst | |
---|---|---|---|
28.01.2009 | Tenet Healthcare underperform | RBC Capital Markets | |
01.10.2008 | Tenet Healthcare Downgrade | UBS AG | |
08.11.2007 | Tenet Healthcare underweight | Lehman Brothers Inc. | |
08.11.2007 | Tenet Healthcare underperform | Cowen and Company, LLC | |
11.09.2007 | Tenet Healthcare underweight | Lehman Brothers Inc. |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Tenet Healthcare Corp. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen